Sofinnova Ventures »

Evommune shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.6M 153k 17.12

More positions owned by Sofinnova Ventures

Natera (NTRA)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Astrazeneca Sponsored Adr
Vera Therapeutics Cl A (VERA)
Bristol Myers Squibb (BMY)
United Therapeutics Corporation (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Abbvie (ABBV)
Intuitive Surgical (ISRG)
Cogent Biosciences (COGT)
Eli Lilly & Co. (LLY)
Rapport Therapeutics (RAPP)
Bridgebio Pharma (BBIO)
Avidity Biosciences Ord (RNA)
Dyne Therapeutics (DYN)

View all positions for Sofinnova Ventures

Top funds holding Evommune

EQT Fund Management S.a r.l.
Pivotal bioVenture Partners Investment Advisor
Nan Fung Group Holdings
Rtw Investments
Marshall Wace
Eventide Asset Management
Sectoral Asset Management
Verition Fund Management
Standard Life Aberdeen
Velan Capital Investment Management
Vanguard Group
Octagon Capital Advisors
American Century Companies
Federated Investors
Dr. Jeffrey R. Jay, M.D.

View all funds holding Evommune